HIV-1 specifically encapsidates other nucleic acids than its genomic RNA by Didierlaurent, Ludovic et al.
BioMed  Central
Page 1 of 2
(page number not for citation purposes)
Retrovirology
Open Access Poster presentation
HIV-1 specifically encapsidates other nucleic acids than its genomic 
RNA
Ludovic Didierlaurent*1, Laurent Houzet1,2, Jean-Christophe Paillart3, 
Zakia Morichaud1, Fatima Smagulova1, Stephan Maurel1, Roland Marquet3 
and Marylène Mougel1
Address: 1CNRS UMR 5236-UMI/UMII CPBS - Equipe «Assemblage et Réplication des Rétrovirus », Montpellier, France, 2Molecular Virology 
Section, Laboratory of Molecular Microbiology National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 
Maryland 20892, USA and 3Architecture et Réactivité de l'ARN, UPR9002, CNRS, ULP, Strasbourg, France
* Corresponding author    
Background
HIV particles include two-copies of full-length genomic
RNA (gRNA) that is selectively incorporated into the viral
particles as a non-covalent dimer. RNA packaging into
virus particles is dependent upon specific interaction
between gRNA and the nucleocapsid protein (NC)
domain of the Gag precursor. Selection of the HIV-1
genomic RNA involves the so-called Psi region located
immediately upstream of the gag start codon and folded
into three stem-loops important for genome packaging
(SL1 to SL3). In particular, SL1 mediates RNA dimeriza-
tion, presumably a prerequisite for gRNA packaging. SL2
and SL3 both bind HIV-1 NC, while SL3 seems to act as
the major signal of encapsidation [1]. Little is know about
the mechanism by which Gag selects gRNA for incorpora-
tion into the nascent virions. In addition, the selection
appears weaker than previously thought, since HIV-1 par-
ticles also package cellular and spliced viral RNAs in addi-
tion to gRNA [2]. The determinants and mechanisms
involved in the encapsidation of such non-genomic RNAs
remain undefined.
Results
In order to unravel the mechanisms conferring RNA pack-
aging specificity, we undertook a detailed quantitative
analysis of the RNA content of HIV-1 particles by RT-
qPCR. We determined the relative packaging efficiencies
of all singly- and fully-spliced viral mRNAs and of few dis-
tinct host RNA species (7SL, U6, and GAPDH RNAs) rela-
tive to that of gRNA [3]. We also evaluated the importance
of the different regions of HIV-1 RNA and of the RNA
export pathway on the packaging efficiency. Although the
spliced viral RNA lacks the SL2-SL3 motifs, they were
found selectively packaged into virions. Moreover, the
persistence of SL1 signal in spliced RNA sequences did not
confer packaging ability to these subgenomic RNAs. We
found that packaging of cellular RNAs greatly varied from
one species to another. 7SL RNA was packaged in wt HIV-
1 particles as efficiently as singly- and fully-spliced viral
RNAs, whereas packaging of U6 snRNA was less efficient.
At the opposite, GADPH mRNA was not detectably encap-
sidated into virions. Furthermore, our results showed that
host and viral RNAs were packaged through independent
mechanisms [3].
Conclusion
Recently, we showed that spliced viral RNAs are present in
infectious particles and consequently participate, along
with the unspliced gRNA, to some of the early steps of
infection such as the reverse transcription step [4]. Simi-
larly, packaging of host RNAs could lead to their reverse
transcription in an infected cell. These non-genomic
reverse transcripts may recombine with the viral genome
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and integrate together into the host cell genome leading to
defective viruses or oncogenes production.
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